Ewa A Ogłodek1, Anna M Szota2, Marek J Just3, Danuta M Moś4, Aleksander Araszkiewicz2. 1. Department of Psychiatry, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Toruń, Poland. Electronic address: maxeva@interia.pl. 2. Department of Psychiatry, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Toruń, Poland. 3. Piekary Medical Centre, Department of General Surgery, Municipal Hospital in Piekary Śląskie, Piekary Śląskie, Poland. 4. Health Care Centre Euro-Med Bytom, Bytom, Poland.
Abstract
INTRODUCTION: The co-occurrence of generalized anxiety disorder and personality disorders suggests the existence of association between the neurobiological predispositions leading to the development of these disorders and activation of cytokine system. Pro-inflammatory chemokines such as CCL-5/RANTES (regulated upon activation normal T cell expressed and secreted) and CXCL12/SDF-1 (stromal derived factor) play an important role in immune response. METHODS: A total of 160 participants were enrolled in the study, 120 of whom comprised the study group (people with the dual diagnosis of personality disorder and generalized anxiety disorder). The mean age was 41.4 ± 3.5 years (range: 20-44 years). The control group consisted of 40 healthy individuals in the mean age of 40.8 ± 3.1 years (range: 20-43 years). A blood sample was collected from each participant and the plasma levels of the CCL-2/MCP-1 (monocyte chemoattractant protein-1), RANTES and SDF-1 chemokines were determined by ELISA. RESULTS: Increased levels of MCP-1 and SDF-1 were found both in women and in men versus the control group for all types of personality disorders. The levels of CCL-5 in men were significantly increased versus the control group and significantly higher in women than in men. Neither women nor men with avoidant or obsessive-compulsive personality disorder showed any significant differences in MCP-1 or SFD-1 levels. In subjects with borderline personality disorder, the levels of the study chemokines were higher in women than in men. CONCLUSIONS: Our study has shown the need for determination of proinflammatory interleukins which are considered as biomarkers of personality disorders and generalized anxiety disorders.
INTRODUCTION: The co-occurrence of generalized anxiety disorder and personality disorders suggests the existence of association between the neurobiological predispositions leading to the development of these disorders and activation of cytokine system. Pro-inflammatory chemokines such as CCL-5/RANTES (regulated upon activation normal T cell expressed and secreted) and CXCL12/SDF-1 (stromal derived factor) play an important role in immune response. METHODS: A total of 160 participants were enrolled in the study, 120 of whom comprised the study group (people with the dual diagnosis of personality disorder and generalized anxiety disorder). The mean age was 41.4 ± 3.5 years (range: 20-44 years). The control group consisted of 40 healthy individuals in the mean age of 40.8 ± 3.1 years (range: 20-43 years). A blood sample was collected from each participant and the plasma levels of the CCL-2/MCP-1 (monocyte chemoattractant protein-1), RANTES and SDF-1 chemokines were determined by ELISA. RESULTS: Increased levels of MCP-1 and SDF-1 were found both in women and in men versus the control group for all types of personality disorders. The levels of CCL-5 in men were significantly increased versus the control group and significantly higher in women than in men. Neither women nor men with avoidant or obsessive-compulsive personality disorder showed any significant differences in MCP-1 or SFD-1 levels. In subjects with borderline personality disorder, the levels of the study chemokines were higher in women than in men. CONCLUSIONS: Our study has shown the need for determination of proinflammatory interleukins which are considered as biomarkers of personality disorders and generalized anxiety disorders.
Authors: Elżbieta Małujło-Balcerska; Anna Kumor-Kisielewska; Janusz Szemraj; Tadeusz Pietras Journal: Pharmacol Rep Date: 2022-03-16 Impact factor: 3.919
Authors: Rosa Maza-Quiroga; Nuria García-Marchena; Pablo Romero-Sanchiz; Pedro Araos; Vicente Barrios; María Pedraz; Antonia Serrano; Raquel Nogueira-Arjona; Juan Jesus Ruiz; Maribel Soria; Rafael Campos; Julie Ann Chowen; Jesus Argente; Marta Torrens; Meritxell López-Gallardo; Eva María Marco; Fernando Rodríguez de Fonseca; Francisco Javier Pavón Journal: PeerJ Date: 2017-10-12 Impact factor: 2.984
Authors: Nuria García-Marchena; Pedro Fernando Araos; Vicente Barrios; Laura Sánchez-Marín; Julie A Chowen; María Pedraz; Estela Castilla-Ortega; Pablo Romero-Sanchiz; Guillermo Ponce; Ana L Gavito; Juan Decara; Daniel Silva; Marta Torrens; Jesús Argente; Gabriel Rubio; Antonia Serrano; Fernando Rodríguez de Fonseca; Francisco Javier Pavón Journal: Front Psychiatry Date: 2017-01-18 Impact factor: 4.157
Authors: C Blaney; J Sommer; R El-Gabalawy; C Bernstein; R Walld; C Hitchon; J Bolton; J Sareen; S Patten; A Singer; L Lix; A Katz; J Fisk; R A Marrie Journal: Epidemiol Psychiatr Sci Date: 2020-01-09 Impact factor: 6.892
Authors: Ewa A Ogłodek; Anna M Szota; Marek J Just; Aleksander Araszkiewicz; Adam R Szromek Journal: Neuropsychiatr Dis Treat Date: 2016-04-21 Impact factor: 2.570